Ligand validation:6SI0

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SI0_EPE_B_404	16%	76%	0.192	0.759	0.42	0.53	-	-	1	0	100%	1
8RBB_EPE_B_408	27%	22%	0.128	0.872	1.31	1.94	1	3	0	0	47%	1
8RBA_EPE_B_404	18%	33%	0.171	0.832	1.22	1.41	1	3	0	0	60%	1
8A92_EPE_B_401	17%	26%	0.224	0.875	1.33	1.67	1	1	0	0	60%	1
6SI1_EPE_A_404	14%	77%	0.342	0.894	0.34	0.56	-	-	0	0	100%	1
8RBC_EPE_B_401	13%	38%	0.162	0.733	0.77	1.65	1	3	0	0	80%	1
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
1CZB_EPE_A_300	100%	65%	0.04	0.991	0.69	0.67	-	-	0	0	100%	1
8VCQ_EPE_F_201	100%	60%	0.044	0.984	0.85	0.68	1	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.